Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds (Q41324589)

29 September 2017

Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds (English)

1 reference

29 September 2017

0 references

Wiesje M van der Flier

10

0 references

Philip Scheltens

8

object named as

Philip Scheltens

1 reference

29 September 2017

7

Frederik Barkhof

1 reference

29 September 2017

9

Charlotte E Teunissen

1 reference

29 September 2017

6

Mike P Wattjes

1 reference

29 September 2017

Georg Christian Oeder

1

object named as

Flora H Duits

1 reference

29 September 2017

3

Joan Montaner

1 reference

29 September 2017

Mar Hernandez-Guillamon

2

1 reference

29 September 2017

Jereon D C Goos

4

1 reference

29 September 2017

Alex Montañola

5

1 reference

29 September 2017

5 September 2015

1 reference

Journal of Alzheimer's Disease

29 September 2017

1 reference

29 September 2017

48

1 reference

29 September 2017

711-720

1 reference

29 September 2017

3

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

29 September 2017

1 reference

Cerebral microbleeds: a guide to detection and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Brain microbleeds and Alzheimer's disease: innocent observation or key player?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Metalloproteinases in biology and pathology of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

CSF biomarkers in relationship to cognitive profiles in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Macrophage migration and invasion is regulated by MMP10 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Blood-brain barrier impairment in dementia: current and future in vivo assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Seasonal variation and stability of matrix metalloproteinase-9 activity and tissue inhibitor of matrix metalloproteinase-1 with storage at −80°C

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143186

21 January 2018

Identifiers

DOI

10.3233/JAD-143186

1 reference

29 September 2017

1 reference